FindTrial
Sign In

Comparison of Kushthadi Lepa and Vachadi Lepa in Scabies(skin disease) in children

A randomized standard controlled clinical trial to access the efficacy of Kushthadi Lepa in the management of PAMA in children.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047770
Enrollment
64
Registered
2022-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre Sector No.25 Nigdi Pradhikaran,Pune 411044
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient who will be clinically with two or more symptoms - itching, pain, burning, eruption, discharge. 2) Selection will be irrespective of gender, religion, and socio-economic class, age between 3 to 14 years.

Exclusion criteria

Exclusion criteria: 1) Patient suffering from any other systemic disorders such as Skin TB, Leprosy. 2) Pama associated with immune deficiency disorder such as HIV. 3) Scabies with crust or hyperkeratosis and secondary infection, urticaria etc. 4) Suspected patient for Covid-19.

Design outcomes

Primary

MeasureTime frame
To study efficacy of Kushthadi Lepa and Vachadi Lepa in PAMA (Scabies)Timepoint: 7 days with follow up on 3rd 5th and 7th day—

Secondary

MeasureTime frame
To observe the adverse effect of the drugTimepoint: 7 days with follow up on third and fifth day—

Countries

India

Contacts

Public ContactDr Kadambari Jitendra Jadhav

PDEAs College of Ayurved and Research Centre,Sector No.25 Nigdi Pradhikaran,Pune

drdeodasms@gmail.com9423010818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026